UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Leukemia, 2016-07, Vol.30 (7), p.1456-1464

2016

Volltextzugriff (PDF)

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.966-971

2014

Volltextzugriff (PDF)

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Leukemia, 2015-01, Vol.29 (1), p.137-144

2015

Volltextzugriff (PDF)

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Volltextzugriff (PDF)

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.630-641

2013

Volltextzugriff (PDF)

Effect of measurable (‘minimal’) residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

Leukemia, 2016-10, Vol.30 (10), p.2080-2083

2016

Volltextzugriff (PDF)

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

Leukemia, 2010-07, Vol.24 (7), p.1276-1282

2010

Volltextzugriff (PDF)

Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration

Blood cancer journal (New York), 2015-04, Vol.5 (4), p.e302-e302

2015

Volltextzugriff (PDF)

The quality of life of adult survivors of childhood hematopoietic cell transplant

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.746-754

2010

Volltextzugriff (PDF)

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.739-748

2009

Volltextzugriff (PDF)

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

Leukemia, 2002-09, Vol.16 (9), p.1627-1636

2002

Volltextzugriff (PDF)

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Leukemia, 2010-05, Vol.24 (5), p.909-913

2010

Volltextzugriff (PDF)

Value of routine ‘day 14’ marrow exam in newly diagnosed AML

Leukemia, 2015-01, Vol.29 (1), p.247-249

2015

Volltextzugriff (PDF)

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3244-3254

2001

Volltextzugriff (PDF)

Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony-Stimulating Factor

Blood, 1995-03, Vol.85 (6), p.1655-1658

1995

Volltextzugriff (PDF)

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson

Leukemia, 2014-02, Vol.28 (2), p.289-292

2014

Volltextzugriff (PDF)

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Blood, 2000-02, Vol.95 (4), p.1188-1194

2000

Volltextzugriff (PDF)

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2002-08, Vol.30 (3), p.167-173

2002

Volltextzugriff (PDF)

Unrelated donor marrow transplantation for acute myeloid leukemia : an update of the Seattle experience

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (4), p.397-404

2000

Volltextzugriff (PDF)

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies

Leukemia, 2006-07, Vol.20 (7), p.1295-1297

2006

Volltextzugriff (PDF)

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Clinical pharmacology and therapeutics, 2009-06, Vol.85 (6), p.615-622

2009

Volltextzugriff (PDF)

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Blood, 1999-08, Vol.94 (3), p.1086-1099

1999

Volltextzugriff (PDF)

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3270-3278

1998

Volltextzugriff (PDF)

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia : The effect of leukemic burden, donor HLA-matching, and marrow cell dose

Blood, 1997-06, Vol.89 (11), p.4226-4235

1997

Volltextzugriff (PDF)

Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

Bone marrow transplantation (Basingstoke), 2000, Vol.25 (1), p.85-89

2000

Volltextzugriff (PDF)

1 – 25 von 1.071

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(982)
Mit Volltextzugriff
(780)

Publikationsform

Sprache

Englisch
(1.070)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(682)
Humans
(677)
Life Sciences & Biomedicine
(667)
Biological And Medical Sciences
(471)
Medical Sciences
(451)
Hematology
(438)
Adult
(410)
Female
(403)
Male
(403)
Middle Aged
(359)
Adolescent
(271)
Bone Marrow Transplantation
(265)
Oncology
(242)
Child
(208)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(177)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(176)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(174)
Transplantation
(167)
Pharmacology. Drug Treatments
(157)
Immunology
(153)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(388)
Bone Marrow Transplantation
(94)
Journal Of Clinical Oncology
(55)
Leukemia
(51)
Biology Of Blood And Marrow Transplantation
(37)
Transplantation
(35)
British Journal Of Haematology
(28)
The New England Journal Of Medicine
(24)
Leukemia Research
(19)
Seminars In Hematology
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia

Effect of measurable (‘minimal’) residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration

The quality of life of adult survivors of childhood hematopoietic cell transplant

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

Value of routine ‘day 14’ marrow exam in newly diagnosed AML

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony-Stimulating Factor

Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation

Unrelated donor marrow transplantation for acute myeloid leukemia : an update of the Seattle experience

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia : The effect of leukemic burden, donor HLA-matching, and marrow cell dose

Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

Suchergebnisse filtern